Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms-Reference-Cited by-同舟云学术

Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms

Published:2008-09 Issue:5 Volume:28 Page:941-950
ISSN:0953-816X
Container-title:European Journal of Neuroscience
language:en
Short-container-title:

Author:

Giorgi M.,D’Angelo V.,Esposito Z.,Nuccetelli V.,Sorge R.,Martorana A.,Stefani A.,Bernardi G.,Sancesario G.

Publisher

Wiley

Subject

General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1460-9568.2008.06387.x/fullpdf

Reference65 articles.

1. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum;Andersson;J. Neurosci.,2001

2. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia;Aubert;Ann. Neurol.,2005

3. Enhanced prepoenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenilalanine-induced dyskinesia;Aubert;Biol. Psych.,2007

4. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms;Beavo;Physiol. Rev.,1995

5. Pathophysiology of levo-dopa-induced dyskinesia: potential for new therapies;Bezard;Nat. Rev. Neurosci.,2001

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Chronic Treatment with the Inhibitor of Phosphodiesterase 5 (PDE5), Sildenafil, in Combination with L-DOPA on Asymmetric Behavior and Monoamine Catabolism in the Striatum and Substantia Nigra of Unilaterally 6-OHDA-Lesioned Rats;Molecules;2024-09-11

2. Exploring causal effects of sarcopenia on risk and progression of Parkinson disease by Mendelian randomization;npj Parkinson's Disease;2024-08-28

3. A Novel PDE10A Inhibitor for Tourette Syndrome and Other Movement Disorders;Cells;2024-07-22

4. Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review;Molecular Biology Reports;2024-04-15

5. Sodium nitroprusside enhances stepping test performance and increases medium spiny neurons responsiveness to cortical inputs in a rat model of Levodopa‐induced dyskinesias;European Journal of Neuroscience;2024-02-15